PRA International, Inc. to Exhibit at Hematology Conference
PRA's Vice President of Medical Affairs, Dr. Ute Berger and other representatives from our Scientific and Medical Affairs group will be available to discuss our expertise in hematology and oncology trials. Dr. Berger has nearly 20 years of clinical experience and an extensive background in hematology indications, including leukemia and lymphoma.
Hematology and oncology are among PRA's core therapeutic areas, and we have a proven record of success conducting complex, global studies in several hematology and oncology indications. Our scientific and therapeutic experts are the cornerstone of our work in these areas. Our accomplished physicians and regulatory experts provide skilled consultancy for our client's drug development programs.
For more information about the exhibition, visit www.praintl.com and click on "Events."
About PRA International
PRA International conducts clinical trials in more than 85 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 3000 clinical trials through its 38 global offices.
PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.
To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.
SOURCE PRA International